Adrian Tersteegen

1.4k total citations
22 papers, 917 citations indexed

About

Adrian Tersteegen is a scholar working on Molecular Biology, Pharmacology and Genetics. According to data from OpenAlex, Adrian Tersteegen has authored 22 papers receiving a total of 917 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 5 papers in Pharmacology and 3 papers in Genetics. Recurrent topics in Adrian Tersteegen's work include Cholinesterase and Neurodegenerative Diseases (5 papers), Phosphodiesterase function and regulation (5 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers). Adrian Tersteegen is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (5 papers), Phosphodiesterase function and regulation (5 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers). Adrian Tersteegen collaborates with scholars based in Germany, United States and Netherlands. Adrian Tersteegen's co-authors include Reiner Hedderich, Christina Erb, Martin Hendrix, Rudolf K. Thauer, Pavel I. Nedvetsky, Harald Schmidt, Péter Schmidt, Johannes‐Peter Stasch, Sabine Meurer and Werner Müller‐Esterl and has published in prestigious journals such as Circulation, Journal of Clinical Investigation and Blood.

In The Last Decade

Adrian Tersteegen

22 papers receiving 902 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adrian Tersteegen Germany 10 483 309 223 156 90 22 917
Cherry L. Wainwright United Kingdom 24 474 1.0× 363 1.2× 653 2.9× 257 1.6× 80 0.9× 93 1.6k
Joseph L. Johnson United States 16 270 0.6× 178 0.6× 64 0.3× 235 1.5× 81 0.9× 47 1.4k
María E. Solesio United States 21 661 1.4× 211 0.7× 36 0.2× 137 0.9× 127 1.4× 43 1.2k
Christoph N. Berger Australia 7 985 2.0× 331 1.1× 119 0.5× 39 0.3× 74 0.8× 8 1.5k
An‐Sheng Lee Taiwan 21 394 0.8× 149 0.5× 233 1.0× 127 0.8× 50 0.6× 56 1.2k
Emilie Vessières France 21 546 1.1× 337 1.1× 273 1.2× 61 0.4× 95 1.1× 46 1.3k
Ning Lü China 8 590 1.2× 239 0.8× 130 0.6× 60 0.4× 72 0.8× 14 1.0k
Calum Wilson United Kingdom 18 496 1.0× 281 0.9× 150 0.7× 28 0.2× 27 0.3× 39 991
Haifeng Pei China 18 532 1.1× 324 1.0× 212 1.0× 42 0.3× 47 0.5× 52 1.2k

Countries citing papers authored by Adrian Tersteegen

Since Specialization
Citations

This map shows the geographic impact of Adrian Tersteegen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adrian Tersteegen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adrian Tersteegen more than expected).

Fields of papers citing papers by Adrian Tersteegen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adrian Tersteegen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adrian Tersteegen. The network helps show where Adrian Tersteegen may publish in the future.

Co-authorship network of co-authors of Adrian Tersteegen

This figure shows the co-authorship network connecting the top 25 collaborators of Adrian Tersteegen. A scholar is included among the top collaborators of Adrian Tersteegen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adrian Tersteegen. Adrian Tersteegen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lewis, Timothy A., Manuel Ellermann, Charlotte Kopitz, et al.. (2024). Discovery of BAY 2666605, a Molecular Glue for PDE3A and SLFN12. ACS Medicinal Chemistry Letters. 15(10). 1662–1667. 3 indexed citations
2.
Meier, Heinrich, Alexander Straub, Joachim Mittendorf, et al.. (2024). Discovery and Preclinical Characterization of Fulacimstat (BAY 1142524), a Potent and Selective Chymase Inhibitor As a New Profibrinolytic Approach for Safe Thrombus Resolution. Journal of Medicinal Chemistry. 68(6). 6108–6126. 1 indexed citations
3.
Roehrig, Susanne, Eloísa Jiménez Núñez, Katharina Meier, et al.. (2023). Design and Preclinical Characterization Program toward Asundexian (BAY 2433334), an Oral Factor XIa Inhibitor for the Prevention and Treatment of Thromboembolic Disorders. Journal of Medicinal Chemistry. 66(17). 12203–12224. 14 indexed citations
4.
Meibom, Daniel, André P. Dieskau, Frank Eitner, et al.. (2022). BAY-7081: A Potent, Selective, and Orally Bioavailable Cyanopyridone-Based PDE9A Inhibitor. Journal of Medicinal Chemistry. 65(24). 16420–16431. 7 indexed citations
5.
Heitmeier, Stefan, Mayken Visser, Adrian Tersteegen, et al.. (2022). Pharmacological profile of asundexian, a novel, orally bioavailable inhibitor of factor XIa. Journal of Thrombosis and Haemostasis. 20(6). 1400–1411. 52 indexed citations
6.
Hillisch, Alexander, et al.. (2020). Druggability Assessment for Selected Serine Proteases in a Pharmaceutical Industry Setting. ChemMedChem. 15(21). 2010–2018. 5 indexed citations
7.
Hillisch, Alexander, Kersten M. Gericke, Susanne Roehrig, et al.. (2020). Design, Synthesis, and Pharmacological Characterization of a Neutral, Non-Prodrug Thrombin Inhibitor with Good Oral Pharmacokinetics. Journal of Medicinal Chemistry. 63(21). 12574–12594. 19 indexed citations
8.
Lewis, Timothy A., Luc de Waal, Xiaoyun Wu, et al.. (2018). Abstract 5880: Small-molecule modulators of PDE3/SLFN12 to kill cancer cells. Cancer Research. 78(13_Supplement). 5880–5880. 1 indexed citations
9.
Tinel, Hanna, et al.. (2017). Abstract 13624: A Novel Chymase Inhibitor BAY 1142524 Reduces Fibrosis and Improves Cardiac Function After Myocardial Infarction in Hamster. Circulation. 4 indexed citations
10.
Wunder, Frank, et al.. (2013). Characterization of the Cellular Activity of PDE 4 Inhibitors Using Two Novel PDE 4 Reporter Cell Lines. Molecular Pharmaceutics. 10(10). 3697–3705. 6 indexed citations
11.
Perzborn, Elisabeth, et al.. (2009). Different Characteristics of Direct Factor Xa Inhibitors: In Vitro Comparative Studies of Rivaroxaban and Apixaban.. Blood. 114(22). 4170–4170. 2 indexed citations
12.
Staay, F. Josef van der, Kris Rutten, Lars Bärfacker, et al.. (2008). The novel selective PDE9 inhibitor BAY 73-6691 improves learning and memory in rodents. Neuropharmacology. 55(5). 908–918. 138 indexed citations
13.
Tersteegen, Adrian, et al.. (2007). RIVAROXABAN - AN ORAL, DIRECT FACTOR XA INHIBITOR - BINDS RAPIDLY TO FACTOR XA. Journal of Thrombosis and Haemostasis. 5. P–W. 14 indexed citations
14.
Stasch, Johannes‐Peter, Péter Schmidt, Pavel I. Nedvetsky, et al.. (2006). Targeting the heme-oxidized nitric oxide receptor for selective vasodilatation of diseased blood vessels. Journal of Clinical Investigation. 116(9). 2552–2561. 366 indexed citations
15.
Wunder, Frank, et al.. (2005). Characterization of the First Potent and Selective PDE9 Inhibitor Using a cGMP Reporter Cell Line. Molecular Pharmacology. 68(6). 1775–1781. 101 indexed citations
16.
Fleischmann, P., et al.. (2005). Das weitgehend unbekannte Krankheitsbild des postoperativen permanenten Hypoparathyreoidismus - Konzeption und Validierung eines innovativen Fragebogenmessinstrumentes. Zentralblatt für Chirurgie - Zeitschrift für Allgemeine Viszeral- Thorax- und Gefäßchirurgie. 130(5). 440–448. 8 indexed citations
17.
Wunder, Frank, Adrian Tersteegen, & Martin Hendrix. (2005). Characterization of the novel PDE9 inhibitor BAY 73-6691 using a cGMP reporter cell line. BMC Pharmacology. 5(S1). 1 indexed citations
18.
Tersteegen, Adrian & Reiner Hedderich. (1999). Methanobacterium thermoautotrophicum encodes two multisubunit membrane‐bound [NiFe] hydrogenases. European Journal of Biochemistry. 264(3). 930–943. 79 indexed citations
19.
Thompson, H. S., Adrian Tersteegen, Rudolf K. Thauer, & Reiner Hedderich. (1998). Two malate dehydrogenases in Methanobacterium thermoautotrophicum. Archives of Microbiology. 170(1). 38–42. 26 indexed citations
20.
Tersteegen, Adrian, Dietmar Linder, Rudolf K. Thauer, & Reiner Hedderich. (1997). Structures and Functions of Four Anabolic 2‐Oxoacid Oxidoreductases in Methanobacterium Thermoautotrophicum. European Journal of Biochemistry. 244(3). 862–868. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cherry L. Wainwright Breakdown of academic impact, for papers by Joseph L. Johnson Breakdown of academic impact, for papers by María E. Solesio Breakdown of academic impact, for papers by Christoph N. Berger Breakdown of academic impact, for papers by An‐Sheng Lee Breakdown of academic impact, for papers by Emilie Vessières Breakdown of academic impact, for papers by Ning Lü Breakdown of academic impact, for papers by Calum Wilson Breakdown of academic impact, for papers by Haifeng Pei
Rankless by CCL
2026